|
BBS4 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 8.205500E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.400800E-03 |
| Normal-vs-Stage2 |
6.313400E-01 |
| Normal-vs-Stage3 |
3.3208999999923E-06 |
| Normal-vs-Stage4 |
7.187200E-01 |
| Stage1-vs-Stage2 |
2.250800E-01 |
| Stage1-vs-Stage3 |
1.268270E-02 |
| Stage1-vs-Stage4 |
4.213800E-01 |
| Stage2-vs-Stage3 |
1.095870E-02 |
| Stage2-vs-Stage4 |
6.304000E-01 |
| Stage3-vs-Stage4 |
2.404600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
8.174100E-02 |
| Normal-vs-AfricanAmerican |
1.502770E-01 |
| Normal-vs-Asian |
4.639000E-01 |
| Caucasian-vs-AfricanAmerican |
8.134400E-01 |
| Caucasian-vs-Asian |
3.627200E-01 |
| AfricanAmerican-vs-Asian |
3.281000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.800800E-04 |
| Normal-vs-Female |
8.606400E-01 |
| Male-vs-Female |
3.314000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
3.618500E-04 |
| Normal-vs-Age(41-60Yrs) |
8.018000E-01 |
| Normal-vs-Age(61-80Yrs) |
3.418500E-04 |
| Normal-vs-Age(81-100Yrs) |
4.702600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.661800E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.359780E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.199900E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.949180E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.430200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.910200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.641000E-01 |
| Normal-vs-Grade 2 |
1.308330E-02 |
| Normal-vs-Grade 3 |
8.266600E-01 |
| Normal-vs-Grade 4 |
2.88739999687593E-08 |
| Grade 1-vs-Grade 2 |
8.064000E-02 |
| Grade 1-vs-Grade 3 |
5.426600E-01 |
| Grade 1-vs-Grade 4 |
1.828440E-02 |
| Grade 2-vs-Grade 3 |
4.675200E-01 |
| Grade 2-vs-Grade 4 |
8.22490000000897E-05 |
| Grade 3-vs-Grade 4 |
2.972400E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
1.094390E-01 |
| Normal-vs-ccB subtype |
2.02539999999418E-05 |
| ccA subtype-vs-ccB subtype |
7.823200E-04 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.958600E-03 |
| Normal-vs-N1 |
2.821700E-02 |
| N0-vs-N1 |
5.477400E-01 |
|
|
